Life Financial Statements From 2010 to 2025

LABS Stock   43.90  5.10  13.14%   
Life Science financial statements provide useful quarterly and yearly information to potential Life Science REIT investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Life Science financial statements helps investors assess Life Science's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Life Science's valuation are summarized below:
Gross Profit
14.5 M
Profit Margin
(1.99)
Market Capitalization
153.7 M
Revenue
20.1 M
Earnings Share
(0.11)
There are over fifty-two available fundamental ratios for Life Science, which can be analyzed over time and compared to other ratios. All traders should check Life Science's last-minute fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction.

Life Science Total Revenue

24.08 Million

Check Life Science financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Life Science's main balance sheet or income statement drivers, such as Interest Income of 2.6 M, Interest Expense of 13.4 M or Selling General Administrative of 5.8 M, as well as many indicators such as . Life financial statements analysis is a perfect complement when working with Life Science Valuation or Volatility modules.
  
This module can also supplement various Life Science Technical models . Check out the analysis of Life Science Correlation against competitors.

Life Science Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets447.3 M472.3 M382.2 M
Slightly volatile
Total Current Liabilities13.9 M13.3 M3.6 M
Slightly volatile
Total Stockholder Equity254.3 M255.4 M332.5 M
Slightly volatile
Net Tangible Assets280.5 M315.5 M344 M
Slightly volatile
Property Plant And Equipment Net352.7 M439.6 M241.8 M
Slightly volatile
Current Deferred Revenue3.3 M3.3 M4.6 M
Slightly volatile
Cash12.3 M12.9 M127.6 M
Slightly volatile
Non Current Assets Total483.4 M460.4 M85.3 M
Slightly volatile
Cash And Short Term Investments12.3 M12.9 M127.6 M
Slightly volatile
Net Receivables7.9 M11.6 M3.2 M
Slightly volatile
Common Stock Shares Outstanding280 M315 M343.4 M
Slightly volatile
Liabilities And Stockholders Equity447.3 M472.3 M382.2 M
Slightly volatile
Non Current Liabilities Total90.8 M146 M37.7 M
Slightly volatile
Inventory89.5 M50.4 M141.6 M
Slightly volatile
Other Stockholder Equity270.1 M302.2 M332.3 M
Slightly volatile
Total Liabilities97.6 M146 M39.3 M
Slightly volatile
Total Current Assets12.3 M12.9 M129 M
Slightly volatile
Capital Stock2.8 M3.1 M3.4 M
Slightly volatile
Common Stock2.8 M3.1 M3.4 M
Slightly volatile
Property Plant Equipment153.7 M173 M188.6 M
Slightly volatile
Short and Long Term Debt Total87.1 M97.1 M107.5 M
Slightly volatile
Accounts Payable1.6 M2.1 M1.2 M
Slightly volatile
Net Invested Capital328.4 M352.5 M415.8 M
Slightly volatile
Long Term Investments3.3 M3.6 M4.2 M
Slightly volatile
Short Term Debt28.6 M32.2 M35.1 M
Slightly volatile

Life Science Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income2.6 M4.4 M882.3 K
Slightly volatile
Selling General Administrative5.8 M9.2 M2.2 M
Slightly volatile
Cost Of Revenue6.8 M10.9 M2.6 M
Slightly volatile
Net Income Applicable To Common Shares14.9 M16.7 M18.2 M
Slightly volatile

Life Science Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditures14.4 M27.6 M10.3 M
Slightly volatile
Change To Operating Activities13.6 M15.3 M16.7 M
Slightly volatile
End Period Cash Flow12.3 M12.9 M129.8 M
Slightly volatile
Other Cashflows From Investing Activities15 M14.2 M2.6 M
Slightly volatile
Sale Purchase Of Stock894.4 KM1.1 M
Slightly volatile

Life Fundamental Market Drivers

Cash And Short Term Investments14.3 M

About Life Science Financial Statements

Life Science shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Life Science investors may analyze each financial statement separately, they are all interrelated. The changes in Life Science's assets and liabilities, for example, are also reflected in the revenues and expenses on on Life Science's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue3.3 M3.3 M
Total Revenue22.9 M24.1 M
Cost Of Revenue10.9 M6.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Life Stock Analysis

When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.